4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-16-112919
SVP, Chief Business Officer sold 1,401 shares at $9.41 ($13,183)
From the SEC's structured data for this filing
Trades in this filing
Dahan Michel · SVP, Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-04 | Sale : show line 1 in the form | −1,401 | $9.41 | $13,183 | 74,956 | D |
| Open-market sales · 1,401 sh · avg $9.41 · $13,183 | ||||||
Loading xslF345X03/doc4.xml…